NFXC-TYPE QUINOLONE RESISTANCE IN A CLINICAL ISOLATE OF PSEUDOMONAS-AERUGINOSA

被引:62
作者
FUKUDA, H
HOSAKA, M
IYOBE, S
GOTOH, N
NISHINO, T
HIRAI, K
机构
[1] GUNMA UNIV,SCH MED,DRUG RESISTANCE BACTERIA LAB,MAEBASHI,GUMMA 371,JAPAN
[2] KYOTO PHARMACEUT UNIV,KYOTO,JAPAN
关键词
D O I
10.1128/AAC.39.3.790
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Quinolone resistance gene nqr-T91 in a clinical isolate of Pseudomonas aeruginosa P1481 was cotransducible with catA1 in P. aeruginosa PAO. The nqr-T91 transductant, PKH-T91, was resistant to norfloxacin, imipenem, and chloramphenicol and showed less norfloxacin accumulation than the parent strain did. Loss of the 46-kDa outer membrane protein (D2) and an increase in the 50-kDa outer membrane protein in PKH-T91 were observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lipopolysaccharides in the transductant were also changed. These alterations were considered to be related to lower levels of norfloxacin accumulation in PKH-T91. These genetic and biochemical properties suggested that an nfxC type of quinolone-resistant mutation occurred in a clinical isolate of P. aeruginosa P1481.
引用
收藏
页码:790 / 792
页数:3
相关论文
共 34 条
[1]   THE CLINICAL PROBLEMS OF BACTERIAL-RESISTANCE TO THE NEW QUINOLONES [J].
ACAR, JF ;
FRANCOUAL, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 :207-213
[2]  
AOYAMA H, 1989, REV INFECT DIS S5, V2, pS972
[3]   EMERGENCE OF QUINOLONE-IMIPENEM CROSS-RESISTANCE IN PSEUDOMONAS-AERUGINOSA AFTER FLUOROQUINOLONE THERAPY [J].
AUBERT, G ;
POZZETTO, B ;
DORCHE, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :307-312
[4]   FACTORS INFLUENCING THE ACCUMULATION OF CIPROFLOXACIN IN PSEUDOMONAS-AERUGINOSA [J].
CELESK, RA ;
ROBILLARD, NJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) :1921-1926
[5]   CHARACTERIZATION OF MECHANISMS OF QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA STRAINS ISOLATED INVITRO AND INVIVO DURING EXPERIMENTAL ENDOCARDITIS [J].
CHAMBERLAND, S ;
BAYER, AS ;
SCHOLLAARDT, T ;
WONG, SA ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :624-634
[6]   RESISTANCE TO CIPROFLOXACIN APPEARING DURING THERAPY [J].
CHIN, NX ;
CLYNES, N ;
NEU, HC .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A) :S28-S31
[7]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[8]   PERSISTENCE MECHANISMS IN PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS UNDERGOING CIPROFLOXACIN THERAPY [J].
DIVER, JM ;
SCHOLLAARDT, T ;
RABIN, HR ;
THORSON, C ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1538-1546
[9]   CIPROFLOXACIN THERAPY OF INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA [J].
ERON, LJ ;
HARVEY, L ;
HIXON, DL ;
PORETZ, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :308-310
[10]   NEW NORFLOXACIN RESISTANCE GENE IN PSEUDOMONAS-AERUGINOSA PAO [J].
FUKUDA, H ;
HOSAKA, M ;
HIRAI, K ;
IYOBE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1757-1761